Emerging role of immune cells as drivers of pulmonary fibrosis
The pathogenesis of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and
other forms of interstitial lung disease, involves a complex interplay of various factors …
other forms of interstitial lung disease, involves a complex interplay of various factors …
Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritis
CC Cubero, EC Carmona, PV Casasempere - … Clínica (English Edition), 2021 - Elsevier
Objective To review the available evidence on the impact of rheumatoid arthritis (RA)
treatments in associated diffuse interstitial lung disease (ILD). Methods Systematic review of …
treatments in associated diffuse interstitial lung disease (ILD). Methods Systematic review of …
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
FV Castelino, J Varga - Arthritis research & therapy, 2010 - Springer
Interstitial lung disease (ILD) is a challenging clinical entity associated with multiple
connective tissue diseases, and is a significant cause of morbidity and mortality. Effective …
connective tissue diseases, and is a significant cause of morbidity and mortality. Effective …
The efficacy and safety of pirfenidone combined with immunosuppressant therapy in connective tissue disease-associated interstitial lung disease: a 24-week …
J Wang, X Wang, X Qi, Z Sun, T Zhang, Y Cui… - Frontiers in …, 2022 - frontiersin.org
Objective Interstitial lung disease (ILD) is a common manifestation of connective tissue
disease (CTD) that manifests as several subtypes with significant differences in prognosis. It …
disease (CTD) that manifests as several subtypes with significant differences in prognosis. It …
[HTML][HTML] Therapeutic options for systemic sclerosis related interstitial lung diseases
L Mouthon, A Bérezné, L Guillevin, D Valeyre - Respiratory medicine, 2010 - Elsevier
Interstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly
encountered in patients with diffuse disease. Unlike idiopathic interstitial pneumonias (IIP) …
encountered in patients with diffuse disease. Unlike idiopathic interstitial pneumonias (IIP) …
A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
CJ Ryerson, TJ Corte, JL Myers… - European …, 2021 - Eur Respiratory Soc
Fibrotic interstitial lung diseases (ILDs) frequently have nonspecific and overlapping clinical
and radiological features, resulting in∼ 10–20% of patients with ILD lacking a clear …
and radiological features, resulting in∼ 10–20% of patients with ILD lacking a clear …
Idiopathic interstitial pneumonias with connective tissue diseases features: a review
V Cottin - Respirology, 2016 - Wiley Online Library
A systematic approach is recommended to search for clinical and biological features of
connective tissue disease (CTD) in any patient with interstitial lung disease (ILD). In the …
connective tissue disease (CTD) in any patient with interstitial lung disease (ILD). In the …
Advances in the treatment of rheumatic interstitial lung disease
R Vassallo, CF Thomas - Current opinion in rheumatology, 2004 - journals.lww.com
Interstitial lung disease is common in the rheumatic diseases, may be caused by a variety of
lesions that respond differently to treatment, and may lead to the development of pulmonary …
lesions that respond differently to treatment, and may lead to the development of pulmonary …
Rituximab in severe, treatment‐refractory interstitial lung disease
GJ Keir, TM Maher, D Ming, R Abdullah… - …, 2014 - Wiley Online Library
Background and objective In patients with severe interstitial lung disease (ILD) progressing
despite conventional immunosuppression, rituximab, a B‐lymphocyte depleting monoclonal …
despite conventional immunosuppression, rituximab, a B‐lymphocyte depleting monoclonal …
Management of lung cancer in the patient with interstitial lung disease
AJ Frank, I Dagogo-Jack, IA Dobre, S Tait… - The …, 2023 - academic.oup.com
Patients with interstitial lung disease (ILD), especially those with pulmonary fibrosis, are at
increased risk of developing lung cancer. Management of lung cancer in patients with ILD is …
increased risk of developing lung cancer. Management of lung cancer in patients with ILD is …